Asymmetric dimethylarginine (ADMA) mediates the effect of miRNA-762 on all-cause mortality in patients with coronary artery disease (CAD). (August 2021) - Tselmin, S.; Kleber, M.; Jarzebska, N.; März, W.; Jin, H.; Bornstein, S.R.; Mangoni, A.; Rodionov, R.N.